Vimarsana
Biggest News Aggregation in the World

Babar Basir News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Babar Basir. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Babar Basir Today - Breaking & Trending Today

Heart attack breakthrough: New protocol saves 71% of patients with deadly complication - Vimarsana News

Heart attack breakthrough: New protocol saves 71% of patients with deadly complication

Published results of a large, national heart attack study show that patients with a life-threatening complication known as cardiogenic shock survived at a significantly higher rate when treated with a protocol developed by cardiologists at Henry Ford Health, in collaboration with 80 hospitals nationwide.

National Cardiogenic Shock Initiative Study Results Show Significant Increase in Heart Attack Survival - Vimarsana News

National Cardiogenic Shock Initiative Study Results Show Significant Increase in Heart Attack Survival

Protocol developed by Henry Ford Health cardiologists leading unprecedented nationwide research.

New study to evaluate bleeding complications in patients undergoing high-risk PCI with Impella - Vimarsana News

New study to evaluate bleeding complications in patients undergoing high-risk PCI with Impella

A new multicenter, single-arm, open-label study is the first to exclusively assess bleeding complications in patients undergoing high-risk percutaneous coronary interventions (PCI) with Impella with independent adjudication via a clinical events adjudication committee and will gather meaningful real-world data based on contemporary practice.

Some CPR basics everyone should know in case of emergency - Vimarsana News

Some CPR basics everyone should know in case of emergency

From a heat stroke victim to a potential drowning victim, if a person is unresponsive CPR should be administered right away.

Inotrope Showdown Leaves No Winner in Cardiogenic Shock - Vimarsana News

Inotrope Showdown Leaves No Winner in Cardiogenic Shock

email article Against expectations, critically ill people in cardiogenic shock fared similarly receiving one widely used inotrope or another in the small DOREMI trial. Patients had the same clinical outcomes on milrinone and dobutamine in terms of the study's primary composite outcome (RR 0.90, 95% CI 0.69-1.19) and its individual endpoint components: In-hospital death: 37% vs 43% (RR 0.85, 95% CI 0.60-1.21) Resuscitated cardiac arrest: 7% vs 9% (HR 0.78, 95% CI 0.29-2.07) Receipt of mechanical circulatory support or cardiac transplant: 12% vs 15% (HR 0.78, 95% CI 0.36-1.71) Nonfatal my...